TR199500778A1 - Suda risperidon formülasyonlari. - Google Patents

Suda risperidon formülasyonlari.

Info

Publication number
TR199500778A1
TR199500778A1 TR95/00778A TR9500778A TR199500778A1 TR 199500778 A1 TR199500778 A1 TR 199500778A1 TR 95/00778 A TR95/00778 A TR 95/00778A TR 9500778 A TR9500778 A TR 9500778A TR 199500778 A1 TR199500778 A1 TR 199500778A1
Authority
TR
Turkey
Prior art keywords
water
risperidone formulations
risperidone
formulations
Prior art date
Application number
TR95/00778A
Other languages
English (en)
Inventor
Marc K J Francois
Willy M A C Dries
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26955530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199500778(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TR199500778A1 publication Critical patent/TR199500778A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR95/00778A 1994-07-11 1995-06-29 Suda risperidon formülasyonlari. TR199500778A1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/272,462 US5453425A (en) 1994-07-11 1994-07-11 Risperidone oral formulation
US08/429,435 US5616587A (en) 1994-07-11 1995-04-26 Aqueous risperidone formulations

Publications (1)

Publication Number Publication Date
TR199500778A1 true TR199500778A1 (tr) 1996-10-21

Family

ID=26955530

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/00778A TR199500778A1 (tr) 1994-07-11 1995-06-29 Suda risperidon formülasyonlari.

Country Status (37)

Country Link
US (3) US5453425A (tr)
EP (1) EP0769965B1 (tr)
JP (1) JP2872412B2 (tr)
KR (1) KR100212942B1 (tr)
CN (1) CN1148226C (tr)
AP (1) AP774A (tr)
AT (1) ATE206931T1 (tr)
AU (1) AU684193B2 (tr)
BG (1) BG63070B1 (tr)
BR (1) BR9508253A (tr)
CA (1) CA2194564C (tr)
CY (1) CY2268B1 (tr)
CZ (1) CZ285204B6 (tr)
DE (1) DE69523313T2 (tr)
DK (1) DK0769965T3 (tr)
EE (1) EE03426B1 (tr)
ES (1) ES2165918T3 (tr)
FI (1) FI116510B (tr)
HK (1) HK1010691A1 (tr)
HR (1) HRP950397B1 (tr)
HU (1) HU222352B1 (tr)
IL (1) IL114525A (tr)
MX (1) MX9700374A (tr)
MY (1) MY114389A (tr)
NO (1) NO320366B1 (tr)
NZ (1) NZ289432A (tr)
PH (1) PH31626A (tr)
PL (1) PL179972B1 (tr)
PT (1) PT769965E (tr)
RO (1) RO116778B1 (tr)
RU (1) RU2161965C2 (tr)
SI (1) SI9500220B (tr)
SK (1) SK282159B6 (tr)
TR (1) TR199500778A1 (tr)
TW (1) TW420615B (tr)
WO (1) WO1996001652A1 (tr)
ZA (1) ZA955720B (tr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354270B1 (ko) * 1993-11-19 2003-02-11 알커메스 컨트롤드 테라포이틱스 인코퍼레이티드 Ii 마이크로캡슐화된3-피페리디닐-치환된1,2-벤즈이속사졸및1,2-벤즈이소티아졸
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20060148826A1 (en) * 2002-08-23 2006-07-06 Ashish Gogia Stable aqueous solutions of risperidone and methods for their preparation
WO2004094414A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Water soluble salts of risperidone
PE20050285A1 (es) 2003-06-24 2005-06-09 Novartis Ag Composicion farmaceutica que comprende analogos ciclicos de somatostatina
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
ES2245252B1 (es) * 2004-06-15 2007-03-01 Farmalider, S.A. Solucion acuosa de risperidona para administracion oral.
ES2245891B1 (es) * 2004-07-09 2006-11-16 Clinmet S.L. "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo".
WO2006129160A2 (en) * 2005-06-01 2006-12-07 Aurobindo Pharma Limited Stable aqueous oral solution of risperidone
ATE424399T1 (de) * 2005-06-29 2009-03-15 Verisfield Uk Ltd Pharmazeutische zusammensetzungen von risperidon in wässriger lösung
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
JP4922657B2 (ja) * 2006-05-09 2012-04-25 高田製薬株式会社 リスペリドン経口用液剤
WO2007138462A2 (en) * 2006-06-01 2007-12-06 Wockhardt Ltd Aqueous oral formulations of risperidone
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
US7776866B2 (en) * 2007-09-15 2010-08-17 Protia, Llc Deuterium-enriched risperidone
CN105560176A (zh) * 2007-12-19 2016-05-11 詹森药业有限公司 与长效注射用帕潘立酮酯相关的给药方案
BRPI1007173A2 (pt) 2009-01-20 2016-02-23 Los Angeles Biomed Res Inst composição farmacêutica compreendendo ácido sórbico e benzóico e seus derivados que melhora a atividade de um neurofármaco, e seu uso, formulação farmacêutica e método de mitigação de um ou mais sintomas de um distúrbio neuropsiquiátrico
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
EP2763676B1 (en) * 2011-10-03 2019-12-25 The University of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
ES2808150T3 (es) 2014-11-07 2021-02-25 Indivior Uk Ltd Regímenes de dosificación de buprenorfina
RU2022101542A (ru) 2016-06-13 2022-02-03 Сайньюрекс Интернэшнл (Тайвань) Корп. Сокристаллы бензоата лития и их применения
US11008277B2 (en) 2016-06-13 2021-05-18 Syneurx International (Taiwan) Corp. Co-crystals of sodium benzoate and uses thereof
WO2018057968A1 (en) * 2016-09-23 2018-03-29 Delpor, Inc. Compositions for small molecule therapeutic agent compounds
US10336679B2 (en) 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
RU2646812C1 (ru) * 2016-10-24 2018-03-07 Общество с ограниченной ответственностью "Трейдсервис" Жидкая лекарственная форма рисперидона и способ ее получения
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
CN107260662A (zh) * 2017-06-21 2017-10-20 南京正科医药股份有限公司 一种利培酮口服溶液及其制备方法
CN107441037A (zh) * 2017-08-16 2017-12-08 南京正科医药股份有限公司 一种利培酮口服溶液
CN109589304A (zh) * 2017-10-01 2019-04-09 万特制药(海南)有限公司 利培酮口服溶液及其制备方法
US10098861B1 (en) 2017-10-24 2018-10-16 Syneurx International (Taiwan) Corp. Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337261A (en) * 1980-07-28 1982-06-29 Hoechst-Roussel Pharmaceuticals Inc. (1,2-Benzisoxazol)phenoxyacetic acids as diuretics
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
FR2641278B1 (fr) * 1989-01-05 1991-03-22 Lipha Piperidines, procedes de preparation et medicaments les contenant
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
FR2796273B1 (fr) * 1999-07-15 2003-09-12 Oreal Composition a phase grasse liquide gelifiee par un polyamide a groupements ester terminaux

Also Published As

Publication number Publication date
PL179972B1 (pl) 2000-11-30
US5453425A (en) 1995-09-26
TW420615B (en) 2001-02-01
NZ289432A (en) 1998-05-27
SI9500220B (sl) 2004-12-31
FI970109A0 (fi) 1997-01-10
FI116510B (fi) 2005-12-15
ES2165918T3 (es) 2002-04-01
CZ2797A3 (en) 1997-07-16
NO970051L (no) 1997-01-07
PL318132A1 (en) 1997-05-12
SK2297A3 (en) 1997-09-10
IL114525A0 (en) 1995-11-27
HU9700082D0 (en) 1997-02-28
PH31626A (en) 1999-01-12
HU222352B1 (hu) 2003-06-28
NO970051D0 (no) 1997-01-07
HRP950397A2 (en) 1997-10-31
DK0769965T3 (da) 2002-02-04
USRE39181E1 (en) 2006-07-11
KR100212942B1 (ko) 1999-08-02
AP774A (en) 1999-10-28
NO320366B1 (no) 2005-11-28
HRP950397B1 (en) 2002-04-30
CN1155247A (zh) 1997-07-23
IL114525A (en) 1999-06-20
MY114389A (en) 2002-10-31
RO116778B1 (ro) 2001-06-29
RU2161965C2 (ru) 2001-01-20
PT769965E (pt) 2002-04-29
DE69523313D1 (de) 2001-11-22
BG101106A (en) 1997-08-29
SK282159B6 (sk) 2001-11-06
AP9700910A0 (en) 1997-01-31
DE69523313T2 (de) 2002-06-27
KR970704472A (ko) 1997-09-06
JP2872412B2 (ja) 1999-03-17
SI9500220A (en) 1996-02-29
CY2268B1 (en) 2003-07-04
FI970109A (fi) 1997-01-10
AU684193B2 (en) 1997-12-04
MX9700374A (es) 1997-04-30
BG63070B1 (bg) 2001-03-30
BR9508253A (pt) 1997-12-23
CN1148226C (zh) 2004-05-05
AU2927595A (en) 1996-02-09
EE9700009A (et) 1997-08-15
CA2194564A1 (en) 1996-01-25
EE03426B1 (et) 2001-06-15
WO1996001652A1 (en) 1996-01-25
JPH09511751A (ja) 1997-11-25
CA2194564C (en) 1997-12-16
ZA955720B (en) 1997-01-10
HUT76826A (en) 1997-11-28
HK1010691A1 (en) 1999-06-25
CZ285204B6 (cs) 1999-06-16
US5616587A (en) 1997-04-01
EP0769965A1 (en) 1997-05-02
EP0769965B1 (en) 2001-10-17
ATE206931T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
TR199500778A1 (tr) Suda risperidon formülasyonlari.
PT941067E (pt) Formulacoes em po estaveis no estado vitreo
DE69720774D1 (de) S-omeprazol in festform
FR2718635B1 (fr) Prothèse cervicale.
ID16283A (id) Senyawa yang berguna dibidang farmasi
DE69205408T2 (de) Mehrzweckstuhl.
TR26120A (tr) SUDA DISPERSIYON OLABILEN GEL FORMüLLERI.
FR2695193B3 (fr) Chauffe-eau combine.
DE59510684D1 (de) Warmwasserspeicher, insbesondere Elektro-Kleinspeicher
ITBZ930033A0 (it) Sci nautico.
KR950022633U (ko) 다용도 물컵
IT241740Y1 (it) Radiatore, in particolare del tipo asciugasalviette
DE9416062U1 (de) Holzspielzeug im Stecksystem
ES1031647Y (es) Caseta multiuso perfeccionada.
ES1032900Y (es) Chaleco-mochila multiuso.
FI3875U1 (fi) Tuolissa käytettävä rakenne
IT241759Y1 (it) Sedia di tipo perfezionato.
KR950010974U (ko) 물놀이용 유희구
SE9600701D0 (sv) Pennan på plats
NO974413D0 (no) Akvakulturteknologi i veksthus
SE9703196D0 (sv) Airbage i framstolarna
KR950025589U (ko) 다용도 자
DE29810011U1 (de) Gerät, insbesondere Wasserheizer oder -speicher
TR199700047U (tr) Su isiticilarinda kullanilan diyaframlarda yenilik.
ITCA940019A0 (it) Impianto fotovoltaico.